Understanding the first signs of HIV and why getting tested regularly is important

The first symptoms of HIV are often similar to the flu, including fever, fatigue, and body aches. However, some people don't ...

ViiV says its HIV PrEP therapy outperformed Gilead’s lenacapavir in early-stage trial

ViiV Healthcare, a healthcare company founded by Pfizer (NYSE:PFE) and GSK (NYSE:GSK), announced on Wednesday that its ...

Immunotherapy approach offers hope for long-term HIV control without daily medication

HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as antiretroviral therapy (ART), are highly effective at suppressing the virus and ...
NBC Los Angeles

Gilead's twice-yearly shot to prevent HIV succeeds in late-stage trial

Gilead's twice-yearly medicine to prevent HIV succeeded in a Phase 3 trial. None of the roughly 2,000 women in the trial who received the lenacapavir shot contracted HIV. Gilead needs to replicate the ...